Stay updated with breaking news from Nasdaq Bntc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price target raised by JMP Securities to $6.50 in a research report released on Tuesday morning, Marketbeat reports. They currently have a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Down 1.6 % Shares of BNTC stock opened at $3.02 on Tuesday. The company […]
Benitec Biopharma (NASDAQ:BNTC – Free Report) had its price objective upped by JMP Securities to $6.50 in a research report report published on Tuesday morning, MarketBeat reports. They currently have a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Stock Performance Shares of BNTC stock opened at $3.07 on Tuesday. The firm’s 50 […]
Benitec Biopharma (NASDAQ:BNTC – Get Free Report) and LumiraDx (NASDAQ:LMDX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk. Institutional and Insider Ownership 9.6% of LumiraDx shares […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totalling 183,000 shares, a drop of 81.2% from the July 15th total of 974,300 shares. Based on an average daily volume of 701,000 shares, […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.97 and traded as low as $2.36. Benitec Biopharma shares last traded at $2.40, with a volume of 62,701 shares trading hands. Benitec Biopharma Trading Down […]